FDA Inspection
Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. – FDA Inspection, Jul 26, 2018
Record Details
This FDA Inspection record concerns Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd., with an inspection on July 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 26, 2018
- Product Type
- Drugs
View Company Profile
ID · 76f31d23-dc60-4c76-a4bd-6bd188cf3544
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1064555
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2025 | Not classified | Office of Inspections and Investigations | |
| June 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
- FDA Inspection 1291762 - 2025-09-12
- FDA Inspection 886759 - 2014-06-12
- FDA Inspection 728837 - 2011-04-28
- FDA Inspection 615933 - 2009-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.